InspireMD (NSPR) Restructuring Costs (2015 - 2025)
InspireMD posted quarterly Restructuring Costs of $1.3 million for Q4 2025, up 21.29% year-on-year from $1.1 million in Q4 2024, and down 29.02% on a QoQ basis from $1.8 million in Q3 2025.
InspireMD (NSPR) has 3 years of Restructuring Costs data on file, last reported at $1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Restructuring Costs rose 21.29% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $6.3 million (up 38.12% YoY), and the FY2025 full-year result was $6.4 million, up 37.72% from the prior year.
- Restructuring Costs for Q4 2025 stood at $1.3 million, down from $1.8 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.8 million in Q3 2025 and bottomed at $1.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2015 | 18,000.00 |
| Sep 30, 2015 | 418,000.00 |
| Jun 30, 2015 | 32,000.00 |